Investigation of Personalis, Inc.
You Have Legal Options
Shareholder Alert: Robbins LLP Reminds Investor It Is Investigating the Officers and Directors of Personalis, Inc. (PSNL) on Behalf of Shareholders
May 20, 2020 (San Diego, CA & Menlo Park, CA) – Shareholder rights law firm Robbins LLP reminds investors it is investigating Personalis, Inc. (NYSE: PSNL) for potential violations of federal securities laws pursuant to its June 2019 initial public offering (“IPO”). Personalis completed its IPO on June 20, 2019, offering shares at $17.00 and raising $140 million in gross proceeds. Four days after the IPO, Personalis stock was trading as high as $31.88 per share. However, by April 27, 2020, shares of Personalis closed at $10.31 per share, representing a decline of almost 40% from its IPO price and a decline of 67% from its record high of $31.88 per share. The stock has yet to recover. Personalis operates as a cancer genomics company worldwide.